No Images? Click here 9 April 2019 Abano - Maven Forced to Stop Buying Dental PracticesNew Zealand Health Group Abano, which owns Australian dental chain “Maven” has had what New Zealand’s Newsroom describes as a painful profit downgrade. Last week Abano said that net profit would fall by 12.6% amidst “challenging” conditions in Australia. Abano’s shares promptly fell from $5.75 the day before to $3.86 on the New Zealand stock market. This is well below its record price of $10.20 in December 2007; its share price having peaked nine months after it rejected a $9.84 per share partial takeover bid. Graham Middleton Disclaimer: The information contained herein is of a general nature and no specific action should be taken without individual advice. Speak with Synstrat staff as appropriate. Prepared by Synstrat Management Pty Ltd for clients of the Synstrat Group. Synstrat Management Pty Ltd is the holder of Australian Financial Services Licence No. 227169. ABN 57 006 295 325 The Synstrat Group provides Accounting, Financial Services, Business Advice, and Financial Advice. Prepared by Synstrat Management Pty Ltd for clients of Synstrat Group. Synstrat Management Pty Ltd P. 03 9843 7777 ABN 57 006 295 325 If you are not the intended recipient of this communication please delete and destroy all copies of this message and telephone Synstrat on +61 3 9843 7777 immediately. If you are the intended recipient of this communication you should not copy, disclose or distribute this communication without the authority of Synstrat. Any views expressed in this communication are those of the individual sender, except wh ere the sender specifically states them to be the views of Synstrat. If you do not wish to receive this email in future, please reply to the sender requesting termination of service. |